HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $984,834 | -80.3% | 25,781 | -81.4% | 0.00% | -83.3% |
| Q2 2023 | $4,990,465 | +586.2% | 138,355 | +626.5% | 0.02% | +500.0% |
| Q1 2023 | $727,290 | -87.8% | 19,044 | -81.8% | 0.00% | -90.6% |
| Q4 2022 | $5,958,340 | +154.0% | 104,716 | +96.4% | 0.03% | +88.2% |
| Q2 2022 | $2,346,000 | +468.0% | 53,329 | +425.3% | 0.02% | +240.0% |
| Q3 2021 | $413,000 | -58.2% | 10,153 | -53.3% | 0.01% | -54.5% |
| Q2 2021 | $987,000 | -52.7% | 21,732 | -56.6% | 0.01% | -66.7% |
| Q1 2021 | $2,087,000 | -20.5% | 50,054 | -18.6% | 0.03% | -10.8% |
| Q4 2020 | $2,626,000 | +713.0% | 61,492 | +401.0% | 0.04% | +640.0% |
| Q3 2020 | $323,000 | -29.6% | 12,273 | -28.3% | 0.01% | -28.6% |
| Q2 2020 | $459,000 | -65.0% | 17,111 | -76.8% | 0.01% | -82.9% |
| Q4 2019 | $1,310,000 | – | 73,897 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |